Deep Track Capital as of Sept. 30, 2022
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 61 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 8.5 | $186M | 1.8M | 103.26 | |
| Iveric Bio Call Option | 7.4 | $162M | 9.0M | 17.94 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.3 | $115M | 861k | 133.29 | |
| Travere Therapeutics (TVTX) | 4.5 | $99M | 4.0M | 24.64 | |
| Novocure Ord Shs (NVCR) | 4.5 | $98M | 1.3M | 75.98 | |
| Horizon Therapeutics Pub L SHS | 4.1 | $91M | 1.5M | 61.89 | |
| Springworks Therapeutics (SWTX) | 3.1 | $68M | 2.4M | 28.53 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.1 | $68M | 2.9M | 23.26 | |
| BioMarin Pharmaceutical (BMRN) | 2.9 | $63M | 739k | 84.77 | |
| Chinook Therapeutics | 2.7 | $59M | 3.0M | 19.66 | |
| Immunovant (IMVT) | 2.5 | $55M | 9.9M | 5.58 | |
| Agenus Com New | 2.5 | $54M | 26M | 2.05 | |
| Beam Therapeutics (BEAM) | 2.2 | $48M | 1.0M | 47.64 | |
| Kura Oncology (KURA) | 2.0 | $44M | 3.2M | 13.66 | |
| Aurinia Pharmaceuticals (AUPH) | 2.0 | $43M | 5.7M | 7.52 | |
| Dyne Therapeutics (DYN) | 1.9 | $40M | 3.2M | 12.70 | |
| Miragen Therapeutics (VRDN) | 1.9 | $40M | 2.0M | 20.51 | |
| Repare Therapeutics Ord (RPTX) | 1.7 | $38M | 3.1M | 12.13 | |
| Acumen Pharmaceuticals (ABOS) | 1.7 | $38M | 3.8M | 10.03 | |
| Esperion Therapeutics (ESPR) | 1.7 | $38M | 5.6M | 6.70 | |
| Nkarta (NKTX) | 1.7 | $37M | 2.8M | 13.16 | |
| Heron Therapeutics (HRTX) | 1.7 | $36M | 8.5M | 4.22 | |
| Edgewise Therapeutics (EWTX) | 1.5 | $33M | 3.4M | 9.84 | |
| Fate Therapeutics (FATE) | 1.3 | $29M | 1.3M | 22.41 | |
| Pliant Therapeutics (PLRX) | 1.3 | $29M | 1.4M | 20.89 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.3 | $29M | 2.8M | 10.22 | |
| Allakos (ALLK) | 1.3 | $28M | 4.5M | 6.12 | |
| Akero Therapeutics (AKRO) | 1.2 | $27M | 791k | 34.05 | |
| Nurix Therapeutics (NRIX) | 1.2 | $27M | 2.1M | 13.03 | |
| Verve Therapeutics (VERV) | 1.2 | $27M | 775k | 34.35 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $27M | 1.8M | 14.51 | |
| 4d Molecular Therapeutics In (FDMT) | 1.2 | $26M | 3.2M | 8.04 | |
| Third Harmonic Bio (THRD) | 1.1 | $24M | 1.3M | 18.97 | |
| Global Blood Therapeutics In | 1.0 | $22M | 327k | 68.10 | |
| Vigil Neuroscience (VIGL) | 1.0 | $22M | 2.4M | 9.10 | |
| Albireo Pharma | 1.0 | $22M | 1.1M | 19.36 | |
| Relmada Therapeutics Call Option (RLMD) | 1.0 | $21M | 578k | 37.02 | |
| Nuvation Bio Com Cl A (NUVB) | 1.0 | $21M | 9.3M | 2.24 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.9 | $21M | 1.1M | 19.64 | |
| Tricida Call Option | 0.9 | $20M | 2.0M | 10.48 | |
| Dice Therapeutics | 0.9 | $20M | 1.0M | 20.28 | |
| Silence Therapeutics Ads (SLN) | 0.9 | $20M | 2.0M | 10.03 | |
| Forma Therapeutics Hldgs SHS | 0.9 | $19M | 967k | 19.95 | |
| Ardelyx (ARDX) | 0.8 | $18M | 15M | 1.19 | |
| Intellia Therapeutics (NTLA) | 0.8 | $17M | 300k | 55.96 | |
| 89bio (ETNB) | 0.7 | $15M | 2.6M | 5.79 | |
| Adicet Bio (ACET) | 0.5 | $12M | 826k | 14.22 | |
| Jounce Therapeutics | 0.5 | $10M | 4.3M | 2.34 | |
| Keros Therapeutics (KROS) | 0.4 | $9.3M | 249k | 37.62 | |
| Anaptysbio Inc Common (ANAB) | 0.4 | $9.2M | 360k | 25.51 | |
| Century Therapeutics (IPSC) | 0.4 | $9.1M | 925k | 9.89 | |
| Inozyme Pharma (INZY) | 0.4 | $8.7M | 3.3M | 2.68 | |
| Reata Pharmaceuticals Cl A Put Option | 0.4 | $8.0M | 317k | 25.13 | |
| Magenta Therapeutics | 0.3 | $7.6M | 5.4M | 1.41 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $7.3M | 901k | 8.09 | |
| Hookipa Pharma Inc equity | 0.3 | $6.7M | 5.0M | 1.34 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $5.8M | 499k | 11.62 | |
| Assembly Biosciences | 0.2 | $4.9M | 3.0M | 1.64 | |
| Schrodinger (SDGR) | 0.2 | $4.2M | 170k | 24.98 | |
| Passage Bio (PASG) | 0.1 | $1.8M | 1.4M | 1.25 | |
| Gritstone Oncology Ord (GRTS) | 0.0 | $117k | 46k | 2.57 |
